Theresa Greco

CIK: 0001998771

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (44.4%)

Compensation grants

Other (G, F, J, C, D, …)5 (55.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OPRX

OptimizeRx Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

OPRX
OptimizeRx Corp
May 15, 2026
Tax Payment(F)
Direct
914 shares at avg. $5.21$5K
OPRX
OptimizeRx Corp
May 15, 2026
Tax Payment(F)
Direct
879 shares at avg. $5.21$5K
OPRX
OptimizeRx Corp
Dec 23, 2025
Tax Payment(F)
Direct
1.4K shares at avg. $12.74$18K
OPRX
OptimizeRx Corp
Nov 1, 2025
Tax Payment(F)
Direct
1.7K shares at avg. $20.49$35K
OPRX
OptimizeRx Corp
Aug 21, 2025
Award(A)
Direct
15.6K shares-
OPRX
OptimizeRx Corp
May 15, 2025
Award(A)
Direct
7K shares-
OPRX
OptimizeRx Corp
May 15, 2025
Award(A)
Direct
2.4K shares-
OPRX
OptimizeRx Corp
Dec 23, 2024
Award(A)
Direct
15.5K shares-
OPRX
OptimizeRx Corp
Nov 1, 2024
Tax Payment(F)
Direct
1.7K shares at avg. $5.15$9K

		Type	Shares	Price		Ownership
May 15, 2026	OPRX OptimizeRx Corp	Tax Payment(F)	914	$5.21	$4,762	Direct
May 15, 2026	OPRX OptimizeRx Corp	Tax Payment(F)	879	$5.21	$4,580	Direct
Dec 23, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	1,420	$12.74	$18,091	Direct
Nov 1, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	1,693	$20.49	$34,690	Direct
Aug 21, 2025	OPRX OptimizeRx Corp	Award(A)	15,625	-	-	Direct
May 15, 2025	OPRX OptimizeRx Corp	Award(A)	7,042	-	-	Direct
May 15, 2025	OPRX OptimizeRx Corp	Award(A)	2,441	-	-	Direct
Dec 23, 2024	OPRX OptimizeRx Corp	Award(A)	15,528	-	$0	Direct
Nov 1, 2024	OPRX OptimizeRx Corp	Tax Payment(F)	1,693	$5.15	$8,719	Direct

1-9 of 9 transactions

About Greco Theresa

Greco Theresa (SEC CIK 0001998771) files insider reports with the SEC as Chief Commercial Officer of OptimizeRx Corp (OPRX).

Signal8 holds 7 ownership filings by Greco Theresa, all Form 4s, filed between Nov 5, 2024 and May 18, 2026. Those filings report 9 transactions, from Nov 1, 2024 to May 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Greco Theresa's filings is in WALTHAM, MA.

Recent filings by Greco Theresa

May 15, 2026: Tax withholdings of OPRX shares (2 lines, Form 4, code F).
Dec 23, 2025: Tax withholding of OPRX shares (Form 4, code F).
Nov 1, 2025: Tax withholding of OPRX shares (Form 4, code F).
Aug 21, 2025: Grant or award of OPRX shares (Form 4, code A).
May 15, 2025: Grants or awards of OPRX shares (2 lines, Form 4, code A).

Other insiders filing for OptimizeRx Corp (OPRX)

D'Silva Andrew J., Chief Business Officer
Silvestro Stephen L, Chief Executive Officer
Merrell Brendan W., CHIEF OPERATING OFFICER
Odence-Ford Marion, Chief Legal & Admin Officer
Stelmakh Edward, Chief Finance & Strat Officer
KLEMA CATHY, Director

How to read Form 4 transaction codes